Eizo Takashima

2.8k total citations
91 papers, 1.6k citations indexed

About

Eizo Takashima is a scholar working on Public Health, Environmental and Occupational Health, Immunology and Molecular Biology. According to data from OpenAlex, Eizo Takashima has authored 91 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Public Health, Environmental and Occupational Health, 38 papers in Immunology and 25 papers in Molecular Biology. Recurrent topics in Eizo Takashima's work include Malaria Research and Control (65 papers), Mosquito-borne diseases and control (51 papers) and Complement system in diseases (16 papers). Eizo Takashima is often cited by papers focused on Malaria Research and Control (65 papers), Mosquito-borne diseases and control (51 papers) and Complement system in diseases (16 papers). Eizo Takashima collaborates with scholars based in Japan, Thailand and United States. Eizo Takashima's co-authors include Takafumi Tsuboi, Kiyoshi Konishi, Masayuki Morita, Hikaru Nagaoka, Bernard N. Kanoi, Daisuke Ito, Yukihiro Takahashi, Tomoko Ishino, Motomi Torii and Kazutoyo Miura and has published in prestigious journals such as Nature, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Eizo Takashima

86 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eizo Takashima Japan 23 1.1k 546 475 269 210 91 1.6k
Katie R. Hughes United Kingdom 13 939 0.9× 455 0.8× 375 0.8× 367 1.4× 203 1.0× 17 1.4k
Satoru Takeo Japan 24 1.1k 1.1× 476 0.9× 442 0.9× 152 0.6× 365 1.7× 43 1.6k
George Hui United States 20 1.1k 1.1× 390 0.7× 680 1.4× 158 0.6× 209 1.0× 44 1.5k
Bruno Douradinha Italy 19 646 0.6× 371 0.7× 252 0.5× 191 0.7× 191 0.9× 39 1.2k
M. Lockyer United Kingdom 19 662 0.6× 719 1.3× 344 0.7× 183 0.7× 113 0.5× 37 1.4k
Daniel Y. Bargieri Brazil 20 788 0.7× 278 0.5× 360 0.8× 222 0.8× 350 1.7× 42 1.2k
Christiaan van Ooij United States 22 1.1k 1.0× 798 1.5× 425 0.9× 305 1.1× 268 1.3× 57 2.3k
Gunjan Arora United States 24 227 0.2× 638 1.2× 290 0.6× 245 0.9× 174 0.8× 61 1.4k
Patrick Caspers Switzerland 20 400 0.4× 706 1.3× 185 0.4× 192 0.7× 65 0.3× 36 1.4k
Nirbhay Kumar United States 27 1.3k 1.2× 607 1.1× 822 1.7× 260 1.0× 425 2.0× 56 2.1k

Countries citing papers authored by Eizo Takashima

Since Specialization
Citations

This map shows the geographic impact of Eizo Takashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eizo Takashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eizo Takashima more than expected).

Fields of papers citing papers by Eizo Takashima

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eizo Takashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eizo Takashima. The network helps show where Eizo Takashima may publish in the future.

Co-authorship network of co-authors of Eizo Takashima

This figure shows the co-authorship network connecting the top 25 collaborators of Eizo Takashima. A scholar is included among the top collaborators of Eizo Takashima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eizo Takashima. Eizo Takashima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tachibana, Mayumi, et al.. (2025). Advances in transmission-blocking vaccines against Plasmodium falciparum and Plasmodium vivax. Expert Review of Vaccines. 24(1). 509–523.
2.
Dini, S, Elizabeth H. Aitken, Timon Damelang, et al.. (2024). A systems serology approach to identifying key antibody correlates of protection from cerebral malaria in Malawian children. BMC Medicine. 22(1). 388–388.
3.
Yamada, Hiroshi, Tadashi Abe, Keiko Kaihara, et al.. (2024). Direct Binding of Synaptopodin 2-Like Protein to Alpha-Actinin Contributes to Actin Bundle Formation in Cardiomyocytes. Cells. 13(16). 1373–1373.
4.
Nagaoka, Hikaru, Felix L. Fennemann, Karina Teelen, et al.. (2023). Pfs230 Domain 7 is targeted by a potent malaria transmission-blocking monoclonal antibody. npj Vaccines. 8(1). 186–186. 5 indexed citations
5.
Kanoi, Bernard N., Hikaru Nagaoka, Jetsumon Sattabongkot, et al.. (2023). High-Throughput Antibody Profiling Identifies Targets of Protective Immunity against P. falciparum Malaria in Thailand. Biomolecules. 13(8). 1267–1267. 3 indexed citations
6.
Huang, Wei‐Chiao, Moustafa T. Mabrouk, Minami Baba, et al.. (2022). Vaccine co-display of CSP and Pfs230 on liposomes targeting two Plasmodium falciparum differentiation stages. Communications Biology. 5(1). 773–773. 20 indexed citations
7.
Miura, Kazutoyo, Eizo Takashima, Thao Pham, et al.. (2022). Elucidating functional epitopes within the N-terminal region of malaria transmission blocking vaccine antigen Pfs230. npj Vaccines. 7(1). 4–4. 10 indexed citations
8.
Longley, Rhea J., Michael White, Jessica Brewster, et al.. (2021). IgG Antibody Responses Are Preferential Compared With IgM for Use as Serological Markers for Detecting Recent Exposure to Plasmodium vivax Infection. Open Forum Infectious Diseases. 8(6). ofab228–ofab228. 9 indexed citations
9.
Sasai, Miwa, Ji Su, Masaaki Okamoto, et al.. (2021). Uncovering a novel role of PLCβ4 in selectively mediating TCR signaling in CD8+ but not CD4+ T cells. The Journal of Experimental Medicine. 218(7). 9 indexed citations
10.
Takashima, Eizo, Mayumi Tachibana, Masayuki Morita, et al.. (2021). Identification of Novel Malaria Transmission-Blocking Vaccine Candidates. Frontiers in Cellular and Infection Microbiology. 11. 805482–805482. 17 indexed citations
11.
Tachibana, Mayumi, Minami Baba, Eizo Takashima, et al.. (2020). The C-terminal region of the Plasmodium yoelii microgamete surface antigen PyMiGS induces potent anti-malarial transmission-blocking immunity in mice. Vaccine. 38(15). 3129–3136. 1 indexed citations
12.
Tougan, Takahiro, Jyotheeswara R. Edula, Masayuki Morita, et al.. (2020). The malaria parasite Plasmodium falciparum in red blood cells selectively takes up serum proteins that affect host pathogenicity. Malaria Journal. 19(1). 155–155. 15 indexed citations
13.
14.
Nagaoka, Hikaru, et al.. (2020). Antibodies against a short region of PfRipr inhibit Plasmodium falciparum merozoite invasion and PfRipr interaction with Rh5 and SEMA7A. Scientific Reports. 10(1). 6573–6573. 16 indexed citations
15.
Tachibana, Mayumi, Kazutoyo Miura, Eizo Takashima, et al.. (2019). Identification of domains within Pfs230 that elicit transmission blocking antibody responses. Vaccine. 37(13). 1799–1806. 37 indexed citations
16.
Tachibana, Mayumi, Tomoko Ishino, Eizo Takashima, Takafumi Tsuboi, & Motomi Torii. (2018). A male gametocyte osmiophilic body and microgamete surface protein of the rodent malaria parasitePlasmodium yoelii(PyMiGS) plays a critical role in male osmiophilic body formation and exflagellation. Cellular Microbiology. 20(5). e12821–e12821. 20 indexed citations
17.
Balikagala, Betty, Toshihiro Mita, Mie Ikeda, et al.. (2017). Absence of in vivo selection for K13 mutations after artemether–lumefantrine treatment in Uganda. Malaria Journal. 16(1). 23–23. 19 indexed citations
18.
Morita, Masayuki, Eizo Takashima, Daisuke Ito, et al.. (2017). Immunoscreening of Plasmodium falciparum proteins expressed in a wheat germ cell-free system reveals a novel malaria vaccine candidate. Scientific Reports. 7(1). 46086–46086. 39 indexed citations
19.
Ntege, Edward Hosea, Nobuko Arisue, Daisuke Ito, et al.. (2016). Identification of Plasmodium falciparum reticulocyte binding protein homologue 5-interacting protein, PfRipr, as a highly conserved blood-stage malaria vaccine candidate. Vaccine. 34(46). 5612–5622. 22 indexed citations
20.
Takashima, Eizo, D.K. Inaoka, Arihiro Osanai, et al.. (2002). Characterization of the dihydroorotate dehydrogenase as a soluble fumarate reductase in Trypanosoma cruzi. Molecular and Biochemical Parasitology. 122(2). 189–200. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Katie R. Hughes Breakdown of academic impact, for papers by Satoru Takeo Breakdown of academic impact, for papers by George Hui Breakdown of academic impact, for papers by Bruno Douradinha Breakdown of academic impact, for papers by M. Lockyer Breakdown of academic impact, for papers by Daniel Y. Bargieri Breakdown of academic impact, for papers by Christiaan van Ooij Breakdown of academic impact, for papers by Gunjan Arora Breakdown of academic impact, for papers by Patrick Caspers Breakdown of academic impact, for papers by Nirbhay Kumar
Rankless by CCL
2026